Corcept Therapeutics Inc $ 24.55 0.695 (2.91%)
Warning! GuruFocus has detected 1 Severe warning sign with CORT. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Corcept Therapeutics Inc () from 2004 to Mar 06 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Corcept Therapeutics stock (CORT) PE ratio as of Mar 06 2021 is 28.89. More Details
Corcept Therapeutics PE Ratio (TTM) Historical Data
View and export this data going back to 2004. Start your Free Trial
Corcept Therapeutics PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:XNCR NAS:IGMS NAS:LGND NAS:EIDX NAS:EPZM NAS:TBPH NAS:ARVN NAS:SWTX NAS:DRNA NAS:MDGL OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 149 Commonwealth Drive, Menlo Park, CA, USA, 94025
Corcept Therapeutics Inc is engaged in the discovery, development, and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.